Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis.

Arteriosclerosis, thrombosis, and vascular biology - 1 Nov 2000

Dewberry R, Holden H, Crossman D, Francis S

Abstract excerpt

The proinflammatory cytokine interleukin (IL)-1 is expressed mainly within the endothelium of atherosclerotic plaques and may be linked with inflammatory mechanisms of atherogenesis. IL-1 action is complex and regulated in part by its naturally occurring inhibitor, the IL-1 receptor antagonist (IL-1ra). Therefore, we studied differential and specific isoform expression of IL-1ra in the endothelium of diseased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arteriosclerosis
Share to Coronary Vessels
Share to Endothelium, Vascular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interleukin 1 Receptor Antagonist Protein

Share to Muscle, Smooth, Vascular

Share to Receptors, Interleukin-1

Share to Sialoglycoproteins

Share to Umbilical Veins

Source

Identifiers

PMID: 11073843
DOI: 10.1161/01.atv.20.11.2394

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis.PMID 11073843Read ↗

Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.Semantic proximity Read ↗

Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.Semantic proximity Read ↗

Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.Semantic proximity Read ↗

Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery DiseaseSemantic proximity Read ↗

Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans.Semantic proximity Read ↗

Interleukin-1 receptor antagonist gene polymorphisms in carotid atherosclerosis.Semantic proximity Read ↗

Physiologic role of interleukin-1 receptor antagonist.Semantic proximity Read ↗

Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Semantic proximity Read ↗

Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke.Semantic proximity Read ↗

Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells.Semantic proximity Read ↗

Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury.Semantic proximity Read ↗

Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.